Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy

[Guest guest]

J Hepatol. 2008 Nov 19. [Epub ahead of print]

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who

discontinued successful entecavir treatment: The case for continuous antiviral

therapy.

Shouval D, Lai CL, Chang TT, Cheinquer H, P, Carosi G, Han S, Kaymakoglu

S, Tamez R, Yang J, Tenney D, Brett- H.

Liver Unit, Hadassah - Hebrew University Hospital, Ein-Kerem, P.O. Box 12000,

Jerusalem 91120, Israel.

BACKGROUND/AIMS: To evaluate the off-treatment durability of response in

HBeAg-negative chronic hepatitis B patients who achieved a protocol-defined

'Response' (HBV-DNA